Should You Think About Buying SyntheticMR AB (publ) (NGM:SYNT) Now?

SyntheticMR AB (publ) (NGM:SYNT), might not be a large cap stock, but it received a lot of attention from a substantial price increase on the NGM over the last few months. As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Let’s take a look at SyntheticMR’s outlook and value based on the most recent financial data to see if the opportunity still exists.

View our latest analysis for SyntheticMR

Is SyntheticMR still cheap?

According to my valuation model, SyntheticMR seems to be fairly priced at around 3.1% below my intrinsic value, which means if you buy SyntheticMR today, you’d be paying a fair price for it. And if you believe that the stock is really worth SEK68.08, then there’s not much of an upside to gain from mispricing. Furthermore, SyntheticMR’s low beta implies that the stock is less volatile than the wider market.

What does the future of SyntheticMR look like?

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Buying a great company with a robust outlook at a cheap price is always a good investment, so let’s also take a look at the company's future expectations. With profit expected to more than double over the next couple of years, the future seems bright for SyntheticMR. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What this means for you:

Are you a shareholder? SYNT’s optimistic future growth appears to have been factored into the current share price, with shares trading around its fair value. However, there are also other important factors which we haven’t considered today, such as the track record of its management team. Have these factors changed since the last time you looked at the stock? Will you have enough confidence to invest in the company should the price drop below its fair value?

Are you a potential investor? If you’ve been keeping tabs on SYNT, now may not be the most optimal time to buy, given it is trading around its fair value. However, the positive outlook is encouraging for the company, which means it’s worth further examining other factors such as the strength of its balance sheet, in order to take advantage of the next price drop.

So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. Be aware that SyntheticMR is showing 2 warning signs in our investment analysis and 1 of those is a bit unpleasant...

If you are no longer interested in SyntheticMR, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.